The FDA originally recommended the vaccines target the coronavirus’ JN.1 variant, but later changed this recommendation to advise manufacturers to focus on the KP.2 strain of the JN line after ...
The FDA approved updated Covid-19 vaccines from Pfizer and Moderna aimed at targeting recent variants, specifically KP.2. These vaccines, suitable for children aged six months and above ...
The U.S. Food and Drug Administration approved two versions of the vaccine Aug. 22: the 2024-2025 Moderna COVID-19 Vaccine and the 2024-2025 Pfizer-BioNTech COVID-19 Vaccine. The Centers for ...